Related Experiment Videos
Lethal irradiation: treatment with immune cell populations
Annals of Plastic Surgery
|March 1, 1979
Summary
Researchers successfully treated irradiated mice using spleen cells without graft-versus-host disease. This method removes harmful cells, offering potential treatments for radiation exposure, cancer, and immune deficiencies.
Area of Science:
- Immunology
- Hematology
- Radiation Biology
Background:
- Graft-versus-host (GVH) disease is a major complication following allogeneic cell transplantation.
- Lethally irradiated recipients are susceptible to GVH reactions, limiting therapeutic options.
Purpose of the Study:
- To develop a method for preventing graft-versus-host disease (GVH) after allogeneic spleen cell transplantation.
- To assess the therapeutic efficacy of GVH-free allogeneic spleen cell inoculation in irradiated mice.
Main Methods:
- Utilized density gradient ultracentrifugation to selectively remove GVH-inducing cells from allogeneic spleen cell populations.
- Administered treated spleen cells to lethally irradiated mice and monitored for GVH reactions and survival.
Main Results:
- Successfully prevented the development of secondary graft-versus-host (GVH) reactions in treated mice.
- Demonstrated successful treatment of lethally irradiated mice using allogeneic spleen cells devoid of GVH-inducing components.
Conclusions:
- Density gradient ultracentrifugation is an effective method for eliminating GVH-reactive cells from allogeneic spleen inoculums.
- This technique holds significant therapeutic potential for treating radiation-exposed individuals, cancer patients, and those with immune deficiencies.